| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | Australia | 4 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | Israel | 4 | |
| #5 | WIPO (World Intellectual Property Organization) | 4 | |
| #6 | Canada | 3 | |
| #7 | Hong Kong | 2 | |
| #8 | Norway | 1 | |
| #9 | New Zealand | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Biotechnology | |
| #4 | Micro-structure and nano-technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Analysing materials | |
| #4 | Peptides | |
| #5 | Nanostructure applications |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wahl Richard L | 11 |
| #2 | Colcher David | 8 |
| #3 | Shochat Dan | 8 |
| #4 | Buckley Michael J | 8 |
| #5 | Chan Albert S K | 8 |
| #6 | Trouet Andre | 7 |
| #7 | Dubois Vincent | 7 |
| #8 | Kroll Stewart M | 6 |
| #9 | Zasadny Kenneth R | 6 |
| #10 | Siegel Jeffry A | 6 |
| Publication | Filing date | Title |
|---|---|---|
| WO0215700A1 | Prodrugs activated by plasmin and their use in cancer chemotherapy | |
| EP1144011A2 | Prodrug compounds and process for preparation thereof | |
| IL140028D0 | Patient specific dosimetry | |
| US5961955A | Radioprotectant for peptides labeled with radioisotope | |
| US5595721A | Radioimmunotherapy of lymphoma using anti-CD20 |